HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.

Abstract
Alterations in the inflammatory and immune systems have been documented to occur from the earliest stages of schizophrenia, and have been associated with neurodevelopmental changes. Cognitive impairment is a core feature in the pathology of schizophrenia, and recent studies showed a significant increase in serum IL-18 in schizophrenia, and a putative role of IL-18 in neuroprogression and thus neurocognitive defects. The purpose of this study was to examine the association of IL-18 with cognitive deficits in schizophrenia. We recruited 77 first episode and drug naïve schizophrenic patients and 75 healthy control subjects and examined the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and serum IL-18 in both groups. Schizophrenic symptoms were assessed using the positive and negative syndrome scale (PANSS). We found that IL-18 levels were non-significantly higher in patients than controls (206.0±92.9 pg/ml vs 193.2±41.8 pg/ml, p=0.28). Cognitive scores on the RBANS and nearly all of its five subscales (all p<0.05) except for the Visuospatial/Constructional index (p>0.05) were significantly lower in schizophrenic patients than normal controls. For the patients, IL-18 was positively associated with the Visuospatial/Constructional domain of cognitive deficits in schizophrenia. Our findings suggest that cognitive deficits occur during the acute stage of a schizophrenic episode, and IL-18 may be involved in Visuospatial/Constructional deficits of these patients.
AuthorsXiang Yang Zhang, Wei Tang, Mei Hong Xiu, Da Chun Chen, Fu De Yang, Yun Long Tan, Zhi Ren Wang, Feixue Zhang, Jiahong Liu, Linjing Liu, Yuanling Chen, Na Wen, Thomas R Kosten
JournalBrain, behavior, and immunity (Brain Behav Immun) Vol. 32 Pg. 105-11 (Aug 2013) ISSN: 1090-2139 [Electronic] Netherlands
PMID23499732 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Interleukin-18
Topics
  • Adolescent
  • Adult
  • Age of Onset
  • Cognition (physiology)
  • Cognition Disorders (complications, psychology)
  • Diagnostic and Statistical Manual of Mental Disorders
  • Female
  • Humans
  • Interleukin-18 (metabolism)
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Psychomotor Performance (physiology)
  • Schizophrenia (metabolism)
  • Schizophrenic Psychology
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: